Inspire Medical announced upcoming presentations and events highlighting its neurostimulator therapy for obstructive sleep apnea at the International Surgical Sleep Society and American Academy of Otolaryngology meetings.
The reimbursement approval provides a pathway to open additional Inspire implanting centers in Belgium, while expanding access to care, according to Inspire Medical Systems.
Inspire Medical Systems Inc has made equity investments in two private companies, EnsoData Inc in Wisconsin and Ognomy Inc in New York.
Children with Down syndrome and sleep apnea are more likely to experience aggressive behavior, brain fogging, and a loss of nearly 10 points in IQ compared to those without.
Read More
Neurostimulators don’t have decades of patient data like CPAP, but Inspire and remedē’s 1- and 5-year outcome studies show sustained benefits.
Read More
Inspire achieved significant therapy utilization milestones in Q4 including the 20,000th patient being implanted with the device.
Read MoreInspire Medical announced Tuesday that its 2021 revenue would be between $233 million and $233.4 million, a robust increase of about 102% over the previous year.
Read More
A second chance for many patients, devices like Inspire and remede also facilitate new avenues for marketing.
Read More
Inspire’s core objective with this report is to allow its customers to make informed decisions related to the best treatment options.
Read MoreCMS will review the panel’s recommendations, and the final rules will be published later in 2021.
Read More
A flow chart from Sleep 360 Sleep Diagnostic Center illustrates the OSA patient journey from referral to customized therapy.
Read More
Many patients give up on CPAP because they can’t tolerate the machine. Implanted neurostimulators may help, but, like positive airway pressure, these new devices can take some getting used to.
Read MoreThis positive coverage decision provides additional OSA patients who are unable to benefit from CPAP the opportunity to gain access to Inspire therapy.”
Read More
Inspire and Japan Lifeline Co Ltd worked closely with the Minister of Health Labour and Welfare to advance the reimbursement application for Inspire therapy, which was approved by an expert panel this month.
Read MoreIt’s been an unusual year. But, mostly as usual, the US Food & Drug Administration continued to review device and drug applications across all fields of medicine.
Read MorePanelists discuss proper patient selection, preparation for device evaluation and the procedure, and post-implant adjustments.
Read More
After more than 20 years of troubled sleep, Dwight Johnson can finally sleep peacefully throughout the night.
Read MoreHealth plan provider Humana Inc will provide coverage for Inspire upper airway stimulation therapy, effective August 27.
Read More